InMed Pharmaceuticals Inc.INMNASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank67
3Y CAGR-28.9%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
-28.9%/yr
vs +14.1%/yr prior
Acceleration
-43.0pp
Decelerating
Percentile
P67
Within normal range
vs 3Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $159573.00 | +165.4% |
| 2025 | $-244138.00 | -152.4% |
| 2024 | $465980.00 | +4.9% |
| 2023 | $444265.00 | +109.2% |
| 2022 | $-4.81M | -905.6% |
| 2021 | $-478137.00 | -325.8% |
| 2020 | $211713.00 | -19.2% |
| 2019 | $262101.00 | +275.6% |
| 2018 | $69774.00 | +14190.9% |
| 2017 | $-495.17 | - |